Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Comment by Hermes8on May 25, 2011 3:07pm
366 Views
Post# 18624409

RE: RE: Timeline for assays accord to webcast

RE: RE: Timeline for assays accord to webcastFrom the webcast on May 11, 2011
E-mail question: "When do you expect the first results from this round of drilling at Brewery Creek?"

Response: "Well, right now there are a number of things that determine when your drilling results come back...the efficiency of our crew getting the rocks to the sample lab and how backed up the sample lab is. During the winter we had very good turnaround as we were about the only ones... In fact, I think we were the only ones submitting samples to the assay lab. So, there are still very few drill programs underway in the Yukon so I think we'll be looking at our first results probably within roughly a two-week period. As the summer progresses this time lag will extend probably close to a month, maybe even longer, because while we have a good relationship with our sample labs the Yukon's going to be full of a number of different companies...possibly as many as 100 with active drill programs this summer. So the strain on the sample labs is going to be like none we've seen before."


Link to May 11, 2011 GPD webcast: https://event.on24.com/r.htm?e=312856&s=1&k=824F602B5A3199BC27A18B51CBBE853F
Listen to the 19:37 to 21:14 mark for verification.


Re: Initial results from this round of drilling at Brewery Creek
Answer: ~2 weeks >> eta May 25?
Current round of drilling: 20 new holes focusing on the extension of mineralization along strike and down dip

Re: Initial results from Grew Creek winter drill program
Answer: ~2 weeks >> eta May 25?

Re: Final results from Grew Creek winter drill program
Answer: within the next 30 days >> eta June 10?
Bullboard Posts